Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 4

Results: 12

Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 441, doi. 10.1007/s00262-016-1944-0

By:

Weide, Benjamin;
Martens, Alexander;
Wistuba-Hamprecht, Kilian;
Zelba, Henning;
Maier, Ludwig;
Lipp, Hans-Peter;
Klumpp, Bernhard;
Soffel, Daniel;
Eigentler, Thomas;
Garbe, Claus

Publication type:

Article

Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 427, doi. 10.1007/s00262-016-1945-z

By:

Pichler, Renate;
Gruenbacher, Georg;
Culig, Zoran;
Brunner, Andrea;
Fuchs, Dietmar;
Fritz, Josef;
Gander, Hubert;
Rahm, Andrea;
Thurnher, Martin

Publication type:

Article

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 461, doi. 10.1007/s00262-016-1946-y

By:

Colado, Ana;
Almejún, María;
Podaza, Enrique;
Risnik, Denise;
Stanganelli, Carmen;
Elías, Esteban;
Dos Santos, Patricia;
Slavutsky, Irma;
Fernández Grecco, Horacio;
Cabrejo, María;
Bezares, Raimundo;
Giordano, Mirta;
Gamberale, Romina;
Borge, Mercedes

Publication type:

Article

Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 451, doi. 10.1007/s00262-016-1948-9

By:

Kavunja, Herbert;
Lang, Shuyao;
Sungsuwan, Suttipun;
Yin, Zhaojun;
Huang, Xuefei

Publication type:

Article

Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 475, doi. 10.1007/s00262-016-1949-8

By:

Chen, Cheng;
Li, Kesang;
Jiang, Hua;
Song, Fei;
Gao, Huiping;
Pan, Xiaorong;
Shi, Bizhi;
Bi, Yanyu;
Wang, Huamao;
Wang, Hongyang;
Li, Zonghai

Publication type:

Article

Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 491, doi. 10.1007/s00262-016-1950-2

By:

Leung, Joanne;
St-Onge, Philippe;
Stagg, John;
Suh, Woong-Kyung

Publication type:

Article

Inclusion of BLIMP-1 effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 515, doi. 10.1007/s00262-016-1951-1

By:

Ward-Hartstonge, Kirsten;
McCall, John;
McCulloch, Timothy;
Kamps, Ann-Kristin;
Girardin, Adam;
Cretney, Erika;
Munro, Fran;
Kemp, Roslyn

Publication type:

Article

Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 503, doi. 10.1007/s00262-016-1953-z

By:

Jordan, Kimberly;
Kapoor, Puja;
Spongberg, Eric;
Tobin, Richard;
Gao, Dexiang;
Borges, Virginia;
McCarter, Martin

Publication type:

Article

Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 523, doi. 10.1007/s00262-017-1955-5

By:

Hartley, Genevieve;
Regan, Daniel;
Guth, Amanda;
Dow, Steven

Publication type:

Article

Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 537, doi. 10.1007/s00262-017-1959-1

By:

Wang, Zhongjuan;
Guo, Linghua;
Song, Yuan;
Zhang, Yinsheng;
Lin, Dandan;
Hu, Bo;
Mei, Yu;
Sandikin, Dedy;
Liu, Haiyan

Publication type:

Article

In memory of Professor Enrico Mihich: Editor-in-Chief of Cancer Immunology, Immunotherapy 1982-2012.

Published in:

2017

By:

Pawelec, Graham;
Ostrand-Rosenberg, Suzanne

Publication type:

Editorial

5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 4, p. 415, doi. 10.1007/s00262-016-1917-3

By:

Stern, Peter;
Harrop, Richard

Publication type:

Article